chromosome-7 bac tile-path array (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
chromosome-7 bac tile-path array
Chromosome 7 Bac Tile Path Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bac+array/pmc03441634-109-11-19
Average 90 stars, based on 1 article reviews
Chromosome 7 Bac Tile Path Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bac+array/pmc03441634-109-11-19
Average 90 stars, based on 1 article reviews
chromosome-7 bac tile-path array - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma"
Article Title: An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma
Journal: PLoS ONE
doi: 10.1371/journal.pone.0044997
Figure Legend Snippet: CGH using the chromosome 7 (Ch7) BAC tile-path array, Agilent 244A oligonucleotide array platform and chromosome 7 gene resolution oligonucleotide array maps the MDR to a 2.8 Mb region at 7q32 (Panel A). As shown by Affymetrix gene expression analyses, the genes on 7q, particularly those within the MDR are significantly under-expressed in SMZL with 7q deletion than those without the deletion. Panel B shows the genes significantly differentially expressed between SMZL with and without 7q deletion according to P values, while Panel C displays those with further fold change more than 1.25×SD (standard deviation).
Techniques Used: Expressing, Standard Deviation
Related Articles
other:Article Title: Inactivation of RUNX3/p46 Promotes Cutaneous T-Cell Lymphoma. Article Snippet: Genomic aberrations of 23 SS patients were analyzed by array comparative genomic hybridization (array CGH) using a submegabase resolution BAC array (Erdogan et al., 2006) (6 patients) or a Article Title: Identification of Copy Number Variants Defining Genomic Differences among Major Human Groups Article Snippet: Three different genome-wide platforms were used to perform the CNV detection: an in-house developed BAC-based array consisting of ∼32.000 BAC-derived probes from the Human 32 K clone set library (kindly provided by Dr. Joris Veltman), a gene-centered oligonucleotide array of Article Title: An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma Article Snippet: summarised the 7q deletion in SMZL detected by CGH using a chromosome-7 BAC tile-path array (17 cases) and the Microarray:Article Title: CGHpower: exploring sample size calculations for chromosomal copy number experiments Article Snippet: .. They will be referred to as Chin et al. [ ], Douglas et al. [ ], Fridlyand et al. [ ], Myllykangas et al. [ ], Nymark et al. [ ], Postma et al. [ ], Smeets et al. [ ] and Wrage et al. [ ] A total of five different array types were used among the data sets: VUmc 30 K spotted oligo [ ] for data sets [ , , ], Agilent Article Title: The Prevalence of Chromosomal Deletions Relating to Developmental Delay and/or Intellectual Disability in Human Euploid Blastocysts Article Snippet: Although the Agilent microarray platform has been used for prenatal diagnosis in human clinics , it has not been applied to human PGS. .. Therefore, in this study, we first validated the BAC Assay:Article Title: CGHpower: exploring sample size calculations for chromosomal copy number experiments Article Snippet: .. They will be referred to as Chin et al. [ ], Douglas et al. [ ], Fridlyand et al. [ ], Myllykangas et al. [ ], Nymark et al. [ ], Postma et al. [ ], Smeets et al. [ ] and Wrage et al. [ ] A total of five different array types were used among the data sets: VUmc 30 K spotted oligo [ ] for data sets [ , , ], Agilent Article Title: The Prevalence of Chromosomal Deletions Relating to Developmental Delay and/or Intellectual Disability in Human Euploid Blastocysts Article Snippet: Although the Agilent microarray platform has been used for prenatal diagnosis in human clinics , it has not been applied to human PGS. .. Therefore, in this study, we first validated the Article Title: Normalization of array-CGH data: influence of copy number imbalances Article Snippet: .. We used eight data sets derived from BAC arrays and from Agilent 244 K Article Title: Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis. Article Snippet: Publication Array platform/design/resolution AMA1 abnormal cases with AMA indication ANX1 abnormal cases with ANX indication 1 Armengol et al. 2012 BAC array 273 0 (2 SL) 60 0 (1 SL) 2 Lee et al 2012 1-Mb resolution BAC array-based CGH and later 60-K oligonucleotide array-based CGH at 0.5-Mb resolution 1891 9 (1 SL) 983 3 (2 SL) 3 Wapner et al. 2012 Agilent 44K (ca. .. 71% of the cohort) and Affymetrix Genome-Wide Human SNP Array 6.0, containing 1.8 million oligonucleotide probes 1966 92 (25 SL) 0 0 4 Shaffer et al. 2012 BAC-based and oligo-based aCGH platforms: SignatureChipWG V1.0, SignatureChipOS V1.0 2, SignatureChip V4.0 or Signature PrenatalChip V1.0 or V2.0 346 1 95 0 5 Breman et al. 2012 BCM Clinical BAC arrays: BAC V4, V5, V6, OLIGO V6, V7, V8 394 52 0 0 6 Fiorentino et al 2013 BAC array - CytoChip Focus Constitutional (BlueGnome, UK) 1Mb resolution across the genome and 100 kb resolution in 139 significant regions 1118 3 (3 SL) 1675 10 (1 SL) 7 Scott et al. Article Title: Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth Article Snippet: .. A: BAC cell lines OE33, OE19, and FLO-1 were treated with wortmannin ... Impact of wortmannin on the genome-wide expression profile in FLO-1 cells To further evaluate the impact of wortmannin in the less sensitive FLO-1 cells, we treated cells with wortmannin (20 μM) for 24 h and conducted a genome wide expression profile, using Agilent Derivative Assay:Article Title: Normalization of array-CGH data: influence of copy number imbalances Article Snippet: .. We used eight data sets derived from BAC arrays and from Agilent 244 K Genome Wide:Article Title: Frequency of submicroscopic chromosomal aberrations in pregnancies without increased risk for structural chromosomal aberrations: systematic review and meta-analysis. Article Snippet: Publication Array platform/design/resolution AMA1 abnormal cases with AMA indication ANX1 abnormal cases with ANX indication 1 Armengol et al. 2012 BAC array 273 0 (2 SL) 60 0 (1 SL) 2 Lee et al 2012 1-Mb resolution BAC array-based CGH and later 60-K oligonucleotide array-based CGH at 0.5-Mb resolution 1891 9 (1 SL) 983 3 (2 SL) 3 Wapner et al. 2012 Agilent 44K (ca. .. 71% of the cohort) and Affymetrix Genome-Wide Human SNP Array 6.0, containing 1.8 million oligonucleotide probes 1966 92 (25 SL) 0 0 4 Shaffer et al. 2012 BAC-based and oligo-based aCGH platforms: SignatureChipWG V1.0, SignatureChipOS V1.0 2, SignatureChip V4.0 or Signature PrenatalChip V1.0 or V2.0 346 1 95 0 5 Breman et al. 2012 BCM Clinical BAC arrays: BAC V4, V5, V6, OLIGO V6, V7, V8 394 52 0 0 6 Fiorentino et al 2013 BAC array - CytoChip Focus Constitutional (BlueGnome, UK) 1Mb resolution across the genome and 100 kb resolution in 139 significant regions 1118 3 (3 SL) 1675 10 (1 SL) 7 Scott et al. Article Title: Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth Article Snippet: .. A: BAC cell lines OE33, OE19, and FLO-1 were treated with wortmannin ... Impact of wortmannin on the genome-wide expression profile in FLO-1 cells To further evaluate the impact of wortmannin in the less sensitive FLO-1 cells, we treated cells with wortmannin (20 μM) for 24 h and conducted a genome wide expression profile, using Agilent Expressing:Article Title: Targeting PI3K and RAD51 in Barrett’s Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth Article Snippet: .. A: BAC cell lines OE33, OE19, and FLO-1 were treated with wortmannin ... Impact of wortmannin on the genome-wide expression profile in FLO-1 cells To further evaluate the impact of wortmannin in the less sensitive FLO-1 cells, we treated cells with wortmannin (20 μM) for 24 h and conducted a genome wide expression profile, using Agilent |
